2020 American Transplant Congress
Analysis of the Quality of Lung Transplantation in Mainland China During 2015- 2018
*Purpose: Lung Transplantation(LT)has been demonstrated as the only effective therapy for patients with end-stage lung diseases. This study aimed to summarize and analyze the data…2020 American Transplant Congress
Evaluation of Optimization of Workflow for Timing of Inpatient Therapeutic Drug Monitoring of Maintenance Immunosuppressive Drugs in Abdominal Transplant Recipients
Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL
*Purpose: Therapeutic drug monitoring (TDM) is essential to the safety and efficacy of immunosuppressants (IS) given their narrow therapeutic index. After an internal review, it…2020 American Transplant Congress
Using Quality Metrics to Improve Access to Living Donor Kidney Transplantation
*Purpose: Living donor kidney transplants (LDKT) are an excellent option for patients with kidney disease. Delays in donor evaluations can impact donor satisfaction as well…2020 American Transplant Congress
The Accuracy of the ICD-10 Diagnostic Codes for Kidney Transplant Rejection and Failure
*Purpose: Clinical research requires that diagnostic codes captured from routinely collected health administrative data accurately identify individuals with a disease. In this study, we examined…2020 American Transplant Congress
Post-Transplant Blood Borne Infectious Disease Testing in Recipients of Increased Risk Donor Livers: A Single Center Experience
University of Washington, Seatttle, WA
*Purpose: Increasing the recovery and utilization of donor livers has become a key goal for transplant programs in the United States over the past decade.…2020 American Transplant Congress
Comparative Analysis of Risk Factors and Outcomes in Kidney Transplant Recipients with Lung Cancer and Those with No Malignancy: UNOS Data Set
*Purpose: Transplant recipients are at increased risk for malignancy. Patients who develop cancer after transplant have worse outcomes, especially those with lung cancer. Transplant-related risk…2020 American Transplant Congress
Viral Kinetics of De Novo HCV Infection and Response to Antiviral Therapy in Liver and Kidney Transplant Recipients Receiving HCV-Viremic Donors
*Purpose: There is general agreement that expanded use of organs from HCV-viremic donors is desirable, including in recipients without HCV infection. However, the optimal treatment…2020 American Transplant Congress
A Data-Driven Approach to Defining the Volume-Outcome Relationship in Renal Transplantation
*Purpose: Advances in immunosuppression and management continually improve short- and long-term outcomes of renal transplantation. However, center volume and expertise, while commonly believed to affect…2020 American Transplant Congress
Report of Organ Offers Linked with Instant Messaging Data Provides a Basis for Quality Improvement
Health Informatics, University of Iowa, Iowa City, IA
*Purpose: Thousands of viable organs are discarded every year with incorrect or inappropriate reasons for declination. One limitation on the accessibility of organ transplantation is…2020 American Transplant Congress
A NASHional Crisis: Liver Transplantation Outcomes in Female Hispanics
1Pathology and Lab Medicine, UCLA, Los Angeles, CA, 2Surgery, UCLA, Los Angeles, CA
*Purpose: Obesity and metabolic syndrome have recently become an epidemic with Hispanics bearing a disproportionate burden. Non-alcoholic steatohepatitis (NASH) is a severe immune-mediated stage of…
- « Previous Page
- 1
- …
- 364
- 365
- 366
- 367
- 368
- …
- 1683
- Next Page »
